Medpace Webinars
-
Navigating The Complexities Of NASH Development: Valuable Insights From A Key Opinion Leader
11/6/2018
In this webinar, medical and operations experts from Medpace facilitate a Q&A session with Dr. Stephen A. Harrison, an experienced Key Opinion Leader (KOL) in NASH. The presenters participate in an in-depth discussion on selected topics associated with NASH development as well as strategies and opportunities for researchers.
-
Opportunities And Challenges In Microbiome-based Clinical Research
11/6/2018
In this webinar, experts from Medpace and Diversigen engage in an interactive discussion on the possibilities as well as the challenges in clinical research and development involving the human microbiome.
-
Latin America: Challenges & Opportunities In Clinical Research
11/6/2018
With an established regulatory environment and a strong healthcare infrastructure, Latin America continues to grow as an advantageous landscape for conducting clinical research. Join Medpace experts Anibal Calmaggi, MD, Senior Medical Director, Infectious Diseases and Vaccines, and Wanda Dobrzanski, MD, Director Clinical Operations, Pediatric infectious diseases and Pharmaceutical medicine specialist, as they share their collective 36 years of experience in designing and managing clinical research in Latin America.
-
Drivers And Trends In Cardiovascular Device Development: Insights From Key Opinion Leaders
11/5/2018
New trends are emerging in medical device development. In this webinar, Dr. Dean J. Kereiakes, a leading Key Opinion Leader in interventional cardiology, shares his expert views on how the cardiovascular medical device world is evolving, and how this field links to daily clinical practice and research. Through panel discussion with Dr. Nicholas Alp and Danny Detiege and through audience interaction, he provides valuable insights into the future of medical device clinical development.
-
Beware The Hidden Costs Of Conducting Clinical Trials: Understanding The Landmines And How To Avoid Them
11/5/2018
In this webinar, we explore four areas that can dramatically affect the cost and timelines of your clinical program and offer insight into elimination and control of these hidden landmines.
-
Gene Editing – Challenges And Future Of CRISPR In Clinical Development
11/5/2018
Gene editing technology is a rapidly evolving area of clinical and translational research that combines the potential of great advances with profound ethical challenges. Join Medpace medical and regulatory experts to discuss the unique opportunity of this evolving technology as it applies to human diseases.